GET DAILY SIGNALSHuron Consulting Group (HURN) Delivers Q3 2026 Earnings Beat with Higher EPS Guidance
Key Takeaways
- Third quarter 2026 total revenue rose 11.4% year over year to $491.5 million, roughly in line with the analyst consensus estimate of $493.2 million.
- Adjusted diluted earnings per share (EPS, or profit allocated to each share) came in at $2.62, about 5.9% above the consensus estimate of $2.47.
- Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) reached $77.34 million, a 15.7% margin, modestly ahead of the $76 million consensus.
- Management narrowed its full-year revenue guidance and raised its adjusted EPS outlook to a $9.30 midpoint, citing a strong backlog and pipeline.
- For more context on this company's Major News, Today's Price Move, Price Targets, and Forecast, explore the additional pages available on Tickeron.
- Discover Trending AI Robots to see how AI-driven trading strategies are navigating current market conditions.
Earnings Context and Why It Matters
Huron Consulting Group (HURN) operates as a global professional services firm focused on healthcare, education, and commercial clients. Its third-quarter 2026 results, covering the period ended September 30, 2026, give investors a useful snapshot of demand trends in those areas and the firm's progress on margin expansion amid recent acquisitions. The company entered the quarter after a strong multi-year stretch, including record performance in the prior period and double-digit growth in revenues before reimbursable expenses (RBR), its key top-line metric. With full-year guidance already raised twice in 2026, this release drew attention for any indications that momentum, utilization, and profitability could carry forward into 2027.
Reported Results
For the third quarter ended September 30, 2026, Huron posted total revenues of $491.5 million, up 11.4% from $441.3 million in the prior-year period. Revenues before reimbursable expenses (RBR) increased to $482.5 million from $432.4 million a year earlier. Total revenue came in close to the consensus estimate of $493.2 million. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Adjusted diluted EPS reached $2.62, surpassing the $2.47 consensus by roughly 5.9%, while adjusted EBITDA of $77.34 million edged past the $76 million consensus. The adjusted operating margin improved to 14.3%, up about three percentage points year over year. Reported operating margin remained near 12%.
Management kept its full-year revenue guidance at a $1.87 billion midpoint and lifted its full-year adjusted EPS guidance to a $9.30 midpoint, underscoring ongoing margin gains and confidence in the backlog and pipeline as 2027 approaches.
Market Reaction and Investor Sentiment
Even with a bottom-line beat and an improved profit outlook, Huron's stock moved lower after the release, per market reports. The response appears tied to the in-line revenue figure and a drop in free cash flow margin to 10% from 21.8% in the same quarter last year. Weaker free cash flow can attract attention despite solid earnings growth. Pre-report sentiment had been constructive after earlier guidance hikes, so the post-earnings dip may reflect some profit-taking or a recalibration of near-term expectations rather than any fundamental change in demand.
Forward Outlook and Key Factors to Monitor
Looking ahead, attention will center on whether Huron can maintain double-digit RBR growth while holding onto margin improvements across its Healthcare, Education, and Commercial segments. The firm highlighted a robust backlog and pipeline to support its narrowed revenue range and raised EPS guidance, yet execution on utilization and acquisition integration will prove critical to hitting those targets.
Cash generation warrants ongoing focus. The free cash flow margin decline this quarter illustrates how working capital timing, integration expenses, and hiring can weigh on cash flow even as profitability rises. Tracking whether free cash flow stabilizes in upcoming quarters will help gauge the durability of the company's capital-return and acquisition plans.
Broader industry conditions also play a role. Demand for consulting and managed services links closely to client spending in healthcare and education, sectors that can shift with funding or regulatory changes. Developments in those areas, combined with Huron's success in securing new business, will influence growth into 2027.
Exploring AI Tools in My Research Process
In reviewing results like these, I sometimes use Tickeron's AI Pattern Search Engine to scan for recurring technical setups across similar professional services names. It helps add another layer to the fundamental picture without replacing core analysis.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Aroon Indicator for HURN shows an upward move is likely
HURN's Aroon Indicator triggered a bullish signal on October 27, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 215 similar instances where the Aroon Indicator showed a similar pattern. In 169 of the 215 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on HURN as a result. In 72 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
The Moving Average Convergence Divergence (MACD) for HURN just turned positive on October 09, 2026. Looking at past instances where HURN's MACD turned positive, the stock continued to rise in 37 of 51 cases over the following month. The odds of a continued upward trend are 73%.
Following a +1.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where HURN advanced for three days, in 213 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HURN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
HURN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 28 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. HURN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 40 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.194) is normal, around the industry mean (13.222). P/E Ratio (29.143) is within average values for comparable stocks, (49.884). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (2.814). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (1.478) is also within normal values, averaging (26.240).
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of management and business consulting services
Industry DataProcessingServices
Advertisement